Sponsor or institution
Clinical trials and research at Boryung Pharmaceutical Co., Ltd
As of November 12, 2026, Find a Trial lists 16 clinical trials run by Boryung Pharmaceutical Co., Ltd that are recruiting, at sites in 2 countries (most in South Korea (16), Indonesia (1)). By phase: Phase 1 (4), Phase 4 (1), Phase 2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 16Clinical trials
- 2Countries
Newest trials
All recruiting trials (16)
-
Olanzapine for people with bipolar disorder
This project tests how people with bipolar disorder use olanzapine and whether teaching them about weight gain helps prevent it.
-
Second- and later-line palliative chemotherapy options for metastatic colorectal cancer.
This study will see how different second- or later-line palliative chemotherapy treatments are used and what outcomes patients with metastatic colorectal cancer have after first-line chemotherapy stops working.
-
Single-pill combination of dapagliflozin, pioglitazone, and metformin versus taking the three drugs separately (fed)
This test will see if a single combination pill of dapagliflozin/pioglitazone/metformin gives the same blood drug levels and safety as taking the three drugs separately in healthy adults after a meal.
-
Compare a single combo pill of dapagliflozin, pioglitazone, and metformin with taking the three drugs separately in fasting adults
This will test whether a single combination tablet of dapagliflozin 10 mg, pioglitazone 30 mg, and metformin 1000 mg gives similar drug levels and is as safe as taking the three medicines separately in healthy adults when fasting.
-
Compare two versions of olaparib (BR2022 and BR2022-1) in people with BRCA-mutated advanced ovarian cancer
This will test whether two formulations of olaparib (BR2022 and BR2022-1) produce similar blood levels and have similar safety in adults with deleterious or suspected deleterious BRCA-mutated advanced ovarian, fallopian tube, or primary peritoneal cancer who are already taking olaparib.
-
Switching a DPP‑4 drug to a TZD for adults on metformin plus an SGLT2 inhibitor
This trial tests whether switching the DPP‑4 pill to a thiazolidinedione (TZD) helps adults with type 2 diabetes who are already taking metformin and an SGLT2 inhibitor.
-
Comparing two treatments for pancreatic cancer
This study is testing two new treatments for pancreatic cancer to see which one is safer and works better for patients.
-
Evaluating a new dosing schedule of olanzapine for schizophrenia treatment
This study is testing a new way to give olanzapine to see if it helps people with schizophrenia feel better and stay safe.
-
Identifying NAFLD risk in type 2 diabetes patients and evaluating a medication combination
This study is testing whether a combination of two diabetes medications can help people with type 2 diabetes reduce their risk of developing non-alcoholic fatty liver disease.
-
Evaluating ethanol effects in breast cancer patients undergoing chemotherapy
This study is testing how safe ethanol is for breast cancer patients getting chemotherapy and if it causes any symptoms before and after their surgery.
-
Evaluating the effectiveness and safety of a combination medication for cholesterol management
This study is testing a new combination medication for cholesterol management to see if it works better and is safe for people who need a change in their current cholesterol treatment.
-
Evaluating a new combination therapy for high blood pressure and diabetes
This study is testing a new combination treatment for people with high blood pressure and type 2 diabetes to see if it works better and is safe compared to their current medications.
-
Evaluating the effects of Pacitol Inj. on patients with chronic kidney disease and secondary hyperparathyroidism
This study is testing if a new injection called Pacitol can help people with severe kidney disease and high parathyroid hormone levels feel better while they are on dialysis.
-
Evaluating the safety and effectiveness of Zepzelca™ injection for small cell lung cancer
This study is testing if the Zepzelca™ injection is safe and effective for people with small cell lung cancer that hasn't improved after their first treatment.
-
Evaluating dapagliflozin for patients with type 2 diabetes and hypertension
This study tests if dapagliflozin can help people with type 2 diabetes and high blood pressure manage their blood sugar and blood pressure better.
-
Evaluating the effectiveness and safety of fixed-dose combinations for treating essential hypertension
This study is testing if a new combination of blood pressure medications can help people with high blood pressure feel better and stay healthy over time.
Quick answers
How many clinical trials run by Boryung Pharmaceutical Co., Ltd are recruiting right now?
16, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in South Korea (16 trials), Indonesia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 4, Phase 4: 1, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.